Childhood Medulloepithelioma Completed Phase 1 Trials for Cilengitide (DB11890)

IndicationStatusPhase
DBCOND0030159 (Childhood Medulloepithelioma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00063973Cilengitide in Treating Children With Refractory Primary Brain TumorsTreatment